European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. (2018) Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA.
Preview | Title | Contact |
---|---|---|
|
PDF (Public health guidance on prevention and control of blood-borne viruses in prison settings)
- Published Version
1MB | |
|
PDF (Summary)
- Supplemental Material
176kB | |
|
PDF (Poster - European evidence-based guidance on prevention and control of HCV in prison settings)
- Supplemental Material
190kB |
This evidence-based guidance aims to support the planning and implementation of effective programmes to prevent and control the transmission of infectious diseases in prison settings in the European region. It focuses on three high-burden blood-borne viruses (BBV) in the prison population, namely hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodefciency virus (HIV). The infections caused by these viruses are characterised by the same modes of blood-borne transmission and similar prevention and control interventions. The key areas covered by this guidance are prevention, treatment and care of BBVs in prison settings.
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > HIV
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Prison-based health service
MM-MO Crime and law > Justice system > Correctional system and facility > Prison
VA Geographic area > Europe
Repository Staff Only: item control page